2183.T Stock - Linical Co., Ltd.
Unlock GoAI Insights for 2183.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $10.44B | $12.31B | $12.52B | $11.56B | $10.28B |
| Gross Profit | $2.01B | $3.78B | $4.16B | $3.61B | $2.77B |
| Gross Margin | 19.2% | 30.7% | 33.2% | 31.3% | 26.9% |
| Operating Income | $-583,500,000 | $725.72M | $1.26B | $1.09B | $453.43M |
| Net Income | $-539,102,000 | $338.27M | $1.00B | $790.49M | $539.97M |
| Net Margin | -5.2% | 2.7% | 8.0% | 6.8% | 5.3% |
| EPS | $-23.87 | $14.98 | $44.47 | $35.00 | $23.91 |
Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariat; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.
Visit WebsiteEarnings History & Surprises
2183.TEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | — | $-33.24 | — | — |
Q2 2025 | May 15, 2025 | — | $-9.84 | — | — |
Q1 2025 | Feb 12, 2025 | — | $-1.61 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-8.78 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-3.64 | — | — |
Q2 2024 | May 15, 2024 | — | $3.75 | — | — |
Q1 2024 | Feb 14, 2024 | — | $3.31 | — | — |
Q4 2023 | Nov 14, 2023 | — | $7.77 | — | — |
Q3 2023 | Aug 14, 2023 | — | $0.16 | — | — |
Q2 2023 | May 15, 2023 | — | $18.90 | — | — |
Q1 2023 | Feb 14, 2023 | — | $4.81 | — | — |
Q4 2022 | Nov 14, 2022 | — | $17.35 | — | — |
Q3 2022 | Aug 12, 2022 | — | $3.41 | — | — |
Q2 2022 | May 16, 2022 | — | $11.76 | — | — |
Q1 2022 | Feb 14, 2022 | — | $12.06 | — | — |
Q4 2021 | Nov 12, 2021 | — | $8.19 | — | — |
Q3 2021 | Aug 12, 2021 | — | $3.00 | — | — |
Q2 2021 | May 14, 2021 | — | $16.95 | — | — |
Q1 2021 | Feb 12, 2021 | — | $7.57 | — | — |
Q4 2020 | Nov 13, 2020 | — | $8.22 | — | — |
Latest News
Frequently Asked Questions about 2183.T
What is 2183.T's current stock price?
What is the analyst price target for 2183.T?
What sector is Linical Co., Ltd. in?
What is 2183.T's market cap?
Does 2183.T pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to 2183.T for comparison